Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) to Ring The Nasdaq Stock Market Closing Bell

ADVISORY, Apr. 16, 2015 (GLOBE NEWSWIRE) --

What: 

Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP ), a clinical stage drug development company focused on the development and commercialization of treatments for rare, life-threatening inflammatory and fibrotic diseases, will visit the Nasdaq MarketSite in Times Square.

In honor of the occasion, Yuval Cohen, Ph.D., Chief Executive Officer, will ring the Closing Bell. 

Where:

Nasdaq MarketSite – 4 Times Square – 43 rd & Broadway – Broadcast Studio

When:

Friday, April 17, 2015 – 3:45 p.m. to 4:00 p.m. ET  

Corbus Pharmaceuticals Holdings, Inc. Media Contact:
David Schull or Marissa Goberdhan
Russo Partners, LLC
+1 (858) 717-2310
david.schull@russopartnersllc.com or marissa.goberdhan@russopartnersllc.com   

Nasdaq MarketSite:
Christine Barna
(646) 441-5310
Christine.Barna@nasdaq.com   

Feed Information:
Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
FEC 3/4
SR 13.235
DR 18.295411
MOD 4:2:0
DVBS QPSK

Social Media:

For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at:  http://www.facebook.com/NASDAQ .

For photos from ceremonies and events visit our Instagram Page:  http://instagram.com/nasdaq  

For news tweets, please visit our Twitter page at:  http://twitter.com/nasdaq  

For exciting viral content and ceremony photos visit Tumblr Page:  http://nasdaq.tumblr.com/  

Webcast:

A webcast of the Nasdaq Closing Bell will be available at: https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx  

Photos: 

To obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.

About Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP ) :

Corbus Pharmaceuticals is a clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare life-threatening inflammatory and fibrotic diseases. The Company’s lead product candidate Resunab™ is a novel oral drug that resolves chronic inflammation and pro-fibrotic processes. Resunab is scheduled to commence Phase 2 clinical trials for the treatment of cystic fibrosis and diffuse cutaneous systemic sclerosis (scleroderma) in 2015. For more information, please visit www.CorbusPharma.com . 

About Nasdaq:

Nasdaq (Nasdaq: NDAQ ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,500 listed companies with a market value of approximately $9.5 trillion and more than 10,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com .

-NDAQA-

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Shareholder Deals Under Fire: PRTH, BWIN, CCC Scrutiny

Updated Category News Views 4

When Deals Leave Shareholders in the Lurch Here's the deal, folks—three companies are under scrutiny for transactions that might leave their shareholders dry while insiders make a pretty penny. Priority Technology Holdings, Inc. (NASDAQ:PRTH), Baldwin Group, Inc. (NASDAQ:BWIN), and CCC Intelligent Solutions Holdings Inc. (NASDAQ:CCC) are being probed by Halper Sadeh LLC...

Continue Reading
ASPR AI Unveils Private Sales Agent Studio

Updated Category News Views 2

Pushing Sales AI Into a Secure Future Picture a world where your most sensitive sales data stays safely behind your own digital doors. ASPR AI is shaking up the game by launching its Private Sales Agent Studio, a move that catapults enterprise sales management into a new era of control and customization. Why Private Means Business Here's the meat of it: sales AI usually...

Continue Reading
Genimous Lands a Role as an OpenAI Select Partner

Updated Category News Views 6

Genimous Teaming Up with OpenAI Genimous just got the nod from OpenAI, bagging a spot as a Select Partner. Now, if you've been paying any attention, you know OpenAI isn’t handing out partnerships like Halloween candy. Genimous got this shiny badge due to its work in digital interaction marketing. We’re talking from gaming to e-commerce, they’ve got the hands in...

Continue Reading
Shareholder Watch: VRNS, DSGR, PSNL Under Scrutiny

Updated Category News Views 5

Navigating Murky Waters: Legal Scrutiny on Shareholder Deals The financial world ain't short on drama these days, and it looks like Varonis Systems, Distribution Solutions Group, and Personalis are right in the thick of it. Each is facing scrutiny over their recent sale transactions that might not be all they’re cracked up to be. Could these deals be shortchanging...

Continue Reading
Veterinary Industry Could Unlock Growth by Empowering Technicians

Updated Category News Views 7

Doors Not Fully Open for Vet Technicians Here's the skinny: the vet industry’s sitting on a goldmine of untapped potential right under its nose. According to a fresh study by Penn Foster, there's a glaring disconnect between what vet techs are trained to handle and what they're actually allowed to do in practice. If practices start trusting these pros to do their thing,...

Continue Reading
Podium Surges Past $150M in AI ARR Milestone

Updated Category News Views 5

A New Era for Podium When the brass at Podium made a gamble on AI, they didn't just try squeezing it into their old business model. Oh no, they launched what feels like a startup within their existing empire—no half-measures, just full-throttle ambition. Fast forward two and a half years, and they've racked up over $150 million in annual recurring revenue from these...

Continue Reading
Rakuten Medical's Long-Term Data Shows Promise

Updated Category News Views 0

This Isn't Just Another Cancer Update Alright, folks, let's unwrap what's happening today with Rakuten Medical. They've thrown some serious numbers into the ring at the ESMO Congress 2026 in Madrid. We're talking long-term follow-up results of their ASP-1929 photoimmunotherapy combined with pembrolizumab in tackling recurrent and metastatic head and neck squamous cell...

Continue Reading
AuraQuantic Leads SPARK Matrix™ in 2026 IPO Ranking

Updated Category News Views 2

Not Just Another Day in Tech When tech outfits make headlines, it's often because of a shiny new gadget or some jarring security breach. Today, it's AuraQuantic getting their well-deserved spotlight, having snagged the leader's spot in the SPARK Matrix™ for Intelligent Process Orchestration (IPO). You might be wondering what makes this accolade worth attention in a...

Continue Reading
Country Stars Illuminate Art in Philly, Mississippi

Updated Category News Views 2

A Mural Tribute to Country Music Roots Forget about skyscrapers and bustling metropolises; sometimes, it's about bringing a bit of soul back to the heartland. That's precisely what the unveiling of the "Wildflowers and Wild Horses" mural in Philadelphia, Mississippi, did. Lainey Wilson and Marty Stuart's Vision Partners in crime — or, more fittingly, in country —...

Continue Reading
Haystack Expands MCP to Boost AI Intranet Workflow

Updated Category News Views 8

Bridging the Intranet and AI: A Game Changer? You ever feel like your company's intranet is a black hole, swallowing all the information you need before spitting it back out in a chaos of outdated pages and broken links? Well, Haystack aims to clear that fog with their Model Context Protocol (MCP) server. And starting October 26, the game takes a leap forward. Now, not...

Continue Reading

Top 5 Most Recently Viewed Articles

Canopy Growth Corporation Faces Class Action Lawsuit Risks

Updated Category News Views 141

Canopy Growth Corporation Faces Class Action Lawsuit Risks Levi & Korsinsky, LLP has recently alerted investors regarding Canopy Growth Corporation, a significant player in the cannabis industry. The firm is representing investors in a class action securities lawsuit aimed at recovering losses faced by those affected by alleged securities fraud. Understanding the Class...

Continue Reading
Moleculin Biotech Shares Insights on Annamycin for STS Treatment

Updated Category News Views 135

Moleculin Biotech’s Recent Developments in Soft Tissue Sarcoma Treatment Moleculin Biotech, Inc. (NASDAQ: MBRX), a prominent pharmaceutical firm, has recently unveiled an on-demand Key Opinion Leader (KOL) webcast. It covers crucial findings from their Phase 1B/2 clinical study, focused on Annamycin's efficacy as a treatment for soft tissue sarcoma (STS) lung...

Continue Reading
Battery Materials Market Growth and Key Industry Drivers

Updated Category News Views 89

Battery Materials Market Growth Prospects The battery materials market is experiencing a significant transformation as we move toward a new era of energy solutions. Fueled by the surge in electric vehicle (EV) sales and the rising need for renewable energy storage, this sector is anticipated to reach a robust valuation in the coming years. According to recent market...

Continue Reading
Iberdrola Honors Global Volunteers Making A Difference Today

Updated Category News Views 138

Back in 2024, Iberdrola threw a bash to honor its unsung heroes—employees who committed themselves to charitable causes around the globe. This wasn't just some corporate back-patting; it was a big deal that highlighted how these folks transformed lives and communities with their relentless spirit. Iberdrola Volunteer Heroes: Recognition That Matters At ScottishPower’s...

Continue Reading
Nordic Capital and Evosep Join Forces for Growth in Proteomics

Updated Category News Views 128

Nordic Capital Forms Strategic Alliance with Evosep Nordic Capital has made headlines with its recent decision to acquire a majority stake in Evosep, an innovative Danish company that specializes in sample preparation and separation solutions primarily for LC-MS-based proteomics. This strategic investment comes as Nordic Capital aims to leverage its extensive experience...

Continue Reading